Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease
Ramón Cacabelos, Arun Meyyazhagan, Juan C. Carril, et al.
Journal of Personalized Medicine (2018) Vol. 8, Iss. 1, pp. 3-3
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy
Christian Griñán‐Ferré, Aina Bellver‐Sanchís, Ana Guerrero, et al.
Pharmacological Research (2024) Vol. 205, pp. 107247-107247
Open Access | Times Cited: 12
The impact of genetic variability on Alzheimer’s therapies: obstacles for pharmacogenetic progress
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2025), pp. 1-28
Closed Access | Times Cited: 1
Schisandra chinensis Fructus and Its Active Ingredients as Promising Resources for the Treatment of Neurological Diseases
Minyu Zhang, Liping Xu, Hongjun Yang
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1970-1970
Open Access | Times Cited: 67
Have there been improvements in Alzheimer’s disease drug discovery over the past 5 years?
Ramón Cacabelos
Expert Opinion on Drug Discovery (2018) Vol. 13, Iss. 6, pp. 523-538
Closed Access | Times Cited: 62
Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders
Shun Zhu, Fang Liu, Ruiyuan Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease
Ramón Cacabelos, Juan C. Carril, Lola Corzo, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 1, pp. 27-57
Closed Access | Times Cited: 22
Symptoms and conventional treatments of Alzheimer's disease
Mehul R. Chorawala, Aayushi C. Shah, Aanshi J. Pandya, et al.
Elsevier eBooks (2024), pp. 213-234
Closed Access | Times Cited: 8
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
Ramón Cacabelos
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3059-3059
Open Access | Times Cited: 48
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease
Ramón Cacabelos
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 8, pp. 673-701
Closed Access | Times Cited: 42
A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
Rima Hajjo, Dima A. Sabbah, Osama H. Abusara, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 2975-2975
Open Access | Times Cited: 25
Genetic Variants and Oxidative Stress in Alzheimer’s Disease
Marta Kowalska, Katarzyna Wize, Michał Prendecki, et al.
Current Alzheimer Research (2020) Vol. 17, Iss. 3, pp. 208-223
Closed Access | Times Cited: 31
Association between chronic periodontitis and the risk of Alzheimer’s disease: combination of text mining and GEO dataset
Zhengye Jiang, Yanxi Shi, Wenpeng Zhao, et al.
BMC Oral Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Personalized Management and Treatment of Alzheimer’s Disease
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, et al.
Life (2022) Vol. 12, Iss. 3, pp. 460-460
Open Access | Times Cited: 13
Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, et al.
Methods in molecular biology (2022), pp. 275-387
Closed Access | Times Cited: 13
Identifying key genes, pathways and screening therapeutic agents for manganese-induced Alzheimer disease using bioinformatics analysis
Junjun Ling, Shengyou Yang, Yi Huang, et al.
Medicine (2018) Vol. 97, Iss. 22, pp. e10775-e10775
Open Access | Times Cited: 20
Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics
Ramón Cacabelos, Iván Carrera, Olaia Martínez, et al.
Medicinal Research Reviews (2021) Vol. 41, Iss. 5, pp. 2841-2886
Closed Access | Times Cited: 12
Population-level pharmacogenomics for precision drug development in dementia
Ramón Cacabelos
Expert Review of Precision Medicine and Drug Development (2018) Vol. 3, Iss. 3, pp. 163-188
Closed Access | Times Cited: 14
Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer’s Disease
Olaia Martínez-Iglesias, Vinogran Naidoo, Iván Carrera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2446-2446
Open Access | Times Cited: 7
Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
María C. Ovejero‐Benito, Dolores Ochoa, Teresa Enrique-Benedito, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 788-788
Open Access | Times Cited: 7
Communicating and Using Dementia Risk Evidence
Allyson Rosen
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 3, pp. 933-944
Open Access | Times Cited: 7
Association of plasma endothelial lipase levels on cognitive impairment
Sang‐Moon Yun, Jee-Yun Park, Sang Won Seo, et al.
BMC Psychiatry (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Identification of core genes in prefrontal cortex and hippocampus of Alzheimer's disease based on mRNA‐miRNA network
Zhi‐Hang Huang, Hai Wang, Dongmei Wang, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 23, pp. 5779-5793
Open Access | Times Cited: 4
Exploratory Analysis of Rare and Novel Variants in Mexican Patients Diagnosed with Schizophrenia and Dementia
José Jaime Martínez‐Magaña, Alma Delia Genis‐Mendoza, Vanessa González-Covarrubias, et al.
Revista de investigaci�n Cl�nica (2019) Vol. 71, Iss. 4
Open Access | Times Cited: 5
Comprehensive Analysis Reveals A Six-Gene Signature and Associated Drugs in Alzheimer Disease
Zhengye Jiang, Guowei Tan, Zhanxiang Wang
Research Square (Research Square) (2020)
Open Access | Times Cited: 3
Pharmacogenetics for Improving Efficacy and Safety in Drug Development and for Reducing Costs in Alzheimer’s Disease
Ramón Cacabelos
Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine (2022) Vol. 19, Iss. 1, pp. 3-6
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top